Functional Outcome in Patients with Subarachnoid Hemorrhage

Overview

About this study

The purpose of this study is to assess outcomes of patients with Subarachnoid Hemorrhage (SAH) and establish their relationship to treatments in a prospective fashion.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  1. Patients (Male or Female) age: 18 to 80 years
  2. Patients with SAH Hunt and Hess Grades 0 to 3 will be included in the study
  3. Patients with Fisher Grades 1 to 4 will be included as well
  4. Ability and willingness to return for follow-up visits
  5. Screening examination corrected or uncorrected near visual acuity of at least 20/200 in at least one eye.
  6. Screening exam corrected or uncorrected auditory acuity of at least having the ability to detect finger rubbing in at least one ear.

Exclusion Criteria:

  1. Patients with Hunt and Hess Grades 4 and 5 will be excluded from the study
  2. Patients with baseline cognitive or functional dysfunction
  3. Patients with a prior history of stroke or a history of intracranial or intraventricular hemorrhage
  4. Patients who cannot participate in neuropsychology evaluations
  5. Cognitive or physical impairment at the time of screening
  6. Pre-existing dementia at the time of screening
  7. Non-English speaking

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Rabih Tawk, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions